Liver carcinoma
|
0.240 |
Biomarker
|
disease |
BEFREE |
Here we examined the role of splicing factors hnRNP A1/A1b and hnRNP A2/B1 in hepatocellular carcinoma (HCC).
|
24572810 |
2014 |
Malignant neoplasm of liver
|
0.210 |
Biomarker
|
disease |
BEFREE |
Therefore, we suggest that the increased expression and cytoplasmic localization of hnRNP A2/B1 can be used as a diagnostic biomarker to assess the risk of human liver cancer.
|
20604928 |
2010 |
Malignant neoplasm of liver
|
0.210 |
Biomarker
|
disease |
RGD |
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
|
23633480 |
2013 |
Transient Ischemic Attack
|
0.200 |
Biomarker
|
disease |
RGD |
Histochemical mapping of hnRNP A2/B1 in rat brain after ischemia-reperfusion insults.
|
20421594 |
2010 |
Diabetes Mellitus, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.
|
18337374 |
2008 |
Liver neoplasms
|
0.200 |
Biomarker
|
group |
RGD |
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
|
23633480 |
2013 |
Hepatoblastoma
|
0.200 |
Biomarker
|
disease |
RGD |
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
|
23633480 |
2013 |
Hepatoblastoma Caused By Somatic Mutation
|
0.200 |
Biomarker
|
disease |
RGD |
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
|
23633480 |
2013 |
Myopathy
|
0.120 |
Biomarker
|
group |
BEFREE |
Ectopic expression of the disease-associated mutant form of hnRNPA2B1 or Hrb98DE in fly muscle resulted in progressive, age-dependent cytoplasmic inclusion pathology, as observed in humans with hnRNPA2B1-related myopathy.
|
26744327 |
2016 |
Myopathy
|
0.120 |
Biomarker
|
group |
HPO |
|
|
|
Myopathy
|
0.120 |
Biomarker
|
group |
BEFREE |
Mutations in the genes encoding the heterogeneous nuclear ribonucleoproteins hnRNPA1 and hnRNPA2/B1 have been reported in a multisystem proteinopathy that includes amyotrophic lateral sclerosis (ALS) and inclusion body myopathy associated with Paget disease of the bone and frontotemporal dementia.
|
29131108 |
2017 |
Frontotemporal dementia
|
0.120 |
Biomarker
|
disease |
BEFREE |
Mutations in the genes encoding the heterogeneous nuclear ribonucleoproteins hnRNPA1 and hnRNPA2/B1 have been reported in a multisystem proteinopathy that includes amyotrophic lateral sclerosis (ALS) and inclusion body myopathy associated with Paget disease of the bone and frontotemporal dementia.
|
29131108 |
2017 |
Frontotemporal dementia
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Aphasia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscular fasciculation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Fatty Liver
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Pathological fracture
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hip joint pain
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Language Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Lordosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscular Dystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Mutism
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myositis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|